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Summary
The report describes successful management of 10 women in 2nd and 3rd pregnancy trimesters
with EchiTab IgG antivenom after carpet viper (Echis ocellatus) envenoming. All women survived
but foetal loss in a victim with delayed presentation and a case of mild hypersensitivity reaction
were recorded. Excellent outcomes can be achieved in rural and semi-nomadic populations
without specialized care and immediate access and provision of effective antivenoms is paramount
in curtailing snakebite maternal morbidity, mortality and foetal loss.
Keywords
antivenom; carpet viper; foetal loss; maternal mobidity; nomads; pregnancy
Introduction
Snakebite is a major medical problem among rural communities of the savanna region of
West Africa, notably in Benin, Burkina-Faso, Cameroon, Ghana, Nigeria and Togo (Warrell
& Arnett 1976). The saw-scaled or carpet viper (Echis ocellatus) has proved to be the most
important cause of snakebite mortality and morbidity in the region. The precise incidence of
snakebite is difficult to determine and is often grossly underestimated, but in parts of the
Nigerian savanna its victims may occupy more than 10% of hospital beds. In the Benue
valley of Nigeria, the estimated incidence is 497 per 100 000 population per year with 10–
20% untreated mortality (Warrell & Arnett 1976; Pugh & Theakston 1980). The main
clinical features of E. ocellatus envenoming are systemic haemorrhage, incoagulable blood,
shock, local swelling, bleeding and occasionally necrosis (Meyer et al. 1997).
In many tropical countries men and women are equally exposed to the environmental and
occupational hazards of snakebite. In a large series of hospital admissions due to snakebite
reported from South Africa, pregnant women accounted for 0.4% of cases (McNally & Reitz
1987). Hospital records are misleading and the true incidence of snakebite is unknown, but it
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may play a significant role in maternal morbidity, mortality and foetal loss in those societies.
During a study in 2006 7 at a rural hospital in northeastern Nigeria, Kaltungo General
Hospital, Gombe state, records of pregnant women who had snakebite were evaluated and
are reported here.
Patients and results
In 2007, 1803 victims of snakebite with 26 deaths were seen at Kaltungo General Hospital.
Snakes that bite the patients were identified when killed and brought to hospital or by
incoagulable blood using the simple 20-min whole blood clotting test [WBCT20] which is
diagnostic of carpet viper in this part of Nigeria (Meyer et al. 1997). More than 90% of the
bites were due to E. ocellatus; 21 were due to Naja spp, four to Bitis arietans and the rest to
Atractaspis spp, Telescopus variegatus or unidentified snakes. Eleven patients were
pregnant, of whom 10 were bitten by E. ocellatus and one by Naja nigricollis (cobra). Eight
of the 10 victims were nomadic or semi-nomadic Fulani maids (Table 1).
An illustrative case is that of a 17 year old Tangale Waja student who was 6 months
pregnant at presentation. She was bitten on the left foot by a carpet viper 6 days prior to
hospitalization while walking to the toilet. No tourniquet was applied but incisions were
made at the bite site. She was treated by a traditional herbalist for 6 days and had vomited
several times after ingesting concoctions. At presentation she was weak and very pale and
her left leg was severely swollen to the hip joint. She had a 3-day history of gum bleeding,
epistaxis and maleana; foetal heart sounds were not heard at presentation. Three millilitre of
fresh whole blood placed in a clean test tube failed to clot within 20 min and she was treated
with slow intravenous 20 ml of EchiTab IgG E. ocellatus monospecific antivenom
(MicroPharm Ltd, London, UK), intravenous hydrocortisone 100 mg and normal saline
alternating with 5% dextrose saline. She achieved restoration of WBCT20 1 day after
admission and was transfused with a pint of fresh whole blood, after which she immediately
and spontaneously delivered a stillbirth. Intravenous ampiclox and metronidazole were
commenced together with oral ferrous sulphate and folic acid. Subsequently, daily WBCT20
did clot, the swelling subsided and the patient was discharged 6 days later after marked
improvement with a 2-week follow up request.
Discussions
This case series suggests that snakebite, in particular carpet viper bite, is a significant cause
of maternal morbidity and foetal loss among underprivileged rural dwellers in the West
African savanna. Foetal loss resulted from delayed presentation in a patient but there are
several possible mechanisms for foetal loss after snakebite: they include the direct effects of
venom on the foetus, foetal hypoxia due to maternal shock, venom-induced uterine
contractions and placental bleeding due to coagulopathy. None of our patients had vaginal
bleeding, although intra-uterine foetal death without bleeding [confirmed using transvaginal
ultrasonography] has been reported (Nasu et al. 2004) and abruptio placentae after snakebite
is a recognized cause of premature labour and foetal wastage (Zugaib et al. 1985; Adam &
Gerais 2005). Snake venom is a mixture of complex biochemical compounds including
potentially tocolytic substances that may induce uterine contractions but their exact role in
premature labour and maternal morbidity is unknown.
In series recording bites from several types of snakes, foetal wastage rates were 28% and
43%, rising to 58% in a subgroup given antivenom, which may reflect the severity of
envenoming (Dunnihoo et al. 1992; Seneviratne et al. 2002). But after bites with
procoagulant/haemorrhagincontaining venoms and with evidence of systemic bleeding,
foetal loss without antivenom use was (1/1) 100% after a pit viper bite (Nasu et al. 2004)
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and with use of antivenom it was 0/1 (0%) after pit viper bite and 4/7 (57%) after Russell’s
viper bite in Sri Lanka (Seneviratne et al. 2002; Chang et al. 2005), a considerably higher
rate than the 1/10 (10%) reported here with timely use of effective antivenom after carpet
viper bite. Previous reports suggested that miscarriage tended to be more common during
the first trimester but our cases and several others confirm that it can occur at other times
during pregnancy (Dunnihoo et al. 1992; Pantanowitz & Guidozzi 1996; Seneviratne et al.
2002; Nasu et al. 2004; Chang et al. 2005; Kravitz & Gerardo 2006). However, it is possible
that mechanisms of foetal loss, maternal morbidity and mortality may vary by gestational
age. Indeed, in advanced pregnancy victims should not be managed supine, as supine
hypotensive syndrome might exacerbate hypotensive shock from envenoming or blood loss
and contribute to mortality (Sutherland et al. 1982). A maternal mortality rate of 10% has
been reported but treatment with antivenoms resulted in good outcome with no death in this
and other series (Dunnihoo et al. 1992; Seneviratne et al. 2002; Chang et al. 2005; Kravitz &
Gerardo 2006). This was achieved mainly because effective antivenoms were used promptly
(mostly within 1 or 2 days of the bite).
Hypersensitivity reactions were noted in 10%; the risk appeared lower than that observed in
non-pregnant and pregnant adults (Meyer et al. 1997; Seneviratne et al. 2002) but
appropriate interventions should be available when antivenoms are administered. Antivenom
may be lifesaving for the mother, but management of reactions with the use of adrenaline
may compromise placental circulation and should be used cautiously and only when
necessary. Birth anomalies and malformations have been reported after experimentally
induced envenoming in pregnant animals and/or their embryos and after bites in pregnant
women (Nawar 1980; Seneviratne et al. 2002). Most (80%) of our patients were nomads,
which precluded follow-up and post-delivery evaluation for defects. Biological agents such
as childhood vaccines, immune globulins and some antivenoms are known to contain
thimerosal [a mercury containing preservative], but prenatal exposure to it was not
associated with neuropsychological deficits in children (Thompson et al. 2007). Pregnant
women are excluded in clinical trials of new agents and managed with the standard of care;
but if the standard of care is clearly sub-optimal, ineffective or non-existent and untreated
mortality reaches 20%, then clinical and ethical decisions should be taken to treat victims
with the new antivenoms after obtaining informed consent, especially when the preliminary
experience is promising. Effective antivenom remains the only specific treatment for
snakebite envenoming and the objective should be safeguarding maternal health while
maximizing the chance of a successful pregnancy.
In the tropics, poisonous snakebite is a problem of vulnerable hard-to-reach societies such as
pastoral or rural communities. To optimize resources, health facilities should be designated
and stocked year-round with the relevant antivenoms to care for victims in high risk areas
like the Benue and Niger valleys and the West African savanna. As at Kaltungo General
Hospital, care-givers should be trained and public awareness increased through media
coverage and sensitization so that victims know where to access care without delay,
avoiding useless, time wasting and potentially harmful traditional remedies. Of our patients
with favourable outcomes eight were treated within 1 day of the bite and one within 2 days.
The delay between bite and antivenom administration may have important consequences for
managing pregnant patients.
We found that excellent outcomes can be achieved even in rural hospitals without
specialized care and that immediate access and provision of effective antivenoms is
paramount in curtailing snakebite maternal morbidity and the double tragedy of maternal
and foetal loss, especially as dangerously inappropriate foreign products are commonly
being marketed by unscrupulous manufacturers in rural Africa (Warrell 2008).
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